This overview of reviews summarizes the evidence from systematic reviews (SR) on the effectiveness of antiretroviral therapy (ART) adherence interventions for people with HIV (PWH) and descriptively compares adherence interventions among key populations. Relevant articles published during 1996–2017 were identified by comprehensive searches of CDC's HIV/acquired immunodeficiency syndrome (AIDS) Prevention Research Synthesis Database and manual searches. Included SRs examined primary interventions intended to improve ART adherence, focused on PWH, and assessed medication adherence or biologic outcomes (e.g., viral load). We synthesized the qualitative data and used the Assessment of Multiple Systematic Reviews (AMSTAR) for quality assessment. Forty-one SRs met inclusion criteria. Average quality was high. SRs that evaluated text-messaging interventions (n = 9) consistently reported statistically significant improvements in adherence and biologic outcomes. Other ART adherence strategies [e.g., behavioral, directly administered antiretroviral therapy (DAART)] reported improvements, but did not report significant effects for both outcomes, or intervention effects that did not persist postintervention. In the review focused on people who inject drugs (n = 1), DAART alone or in combination with medication-assisted therapy improved both outcomes. In SRs focused on children or adolescents aged <18 years (n = 5), regimen-related and hospital-based DAART improved biologic outcomes. ART adherence interventions (e.g., text-messaging) improved adherence and biologic outcomes; however, results differed for other intervention strategies, populations, and outcomes. Because few SRs reported evidence for populations at high risk (e.g., men who have sex with men), the results are not generalizable to all PWH. Future implementation studies are needed to examine medication adherence interventions in specific populations and address the identified gaps.
Get full access to this article
View all access options for this article.
References
1.
CDC. Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014. Atlanta, GA: Centers for Disease Control & Prevention, 2014.
2.
AIDSInfo. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. AIDS Info website, 2010. Available at: https://aidsinfo.nih.gov/contentfiles/Ivguidelines/adultandadolescentgl.pdf
AtkinsonMJ, PetrozzinoJJ. An evidence-based review of treatment-related determinants of patients' nonadherence to HIV medications. AIDS Patient Care STDs, 2009; 23:903–914.
5.
GardnerEM, SharmaS, PengG, et al.Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS, 2008; 22:75–82.
6.
MaggioloF, AiroldiM, KleinloogHD, et al.Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients. HIV Clin Trials, 2007; 8:282–292.
7.
LimaVD, HarriganR, BangsbergDR, et al.The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr, 2009; 50:529–536.
8.
CorlessIB, HoytAJ, Tyer-ViolaL, et al.90-90-90-Plus: Maintaining adherence to antiretroviral therapies. AIDS Patient Care STDS, 2017; 31:227–236.
9.
FuL, HuY, LuHZ. Overviews of reviews on patient compliance with medication protocols used in highly active antiretroviral therapy. Int J Nurs Sci, 2015; 2:61–65.
10.
MbuagbawL, MursleenS, LytvynL, et al.Mobile phone text messaging interventions for HIV and other chronic diseases: An overview of systematic reviews and framework for evidence transfer. BMC Health Serv Res, 2015; 15:33.31–33.16.
11.
MoherD, ShamseerL, ClarkeM, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 2015; 4:1.
12.
LylesCM, CrepazN, HerbstJH, et al.Evidence-based HIV behavioral prevention from the perspective of the CDC's HIV/AIDS Prevention Research Synthesis Team. AIDS Educ Prev, 2006; 18(4 Suppl A):21–31.
13.
DeLucaJB, MullinsMM, LylesCM, et al.Developing a comprehensive search strategy for evidence based systematic reviews. Evid Based Libr Inf Pract, 2008; 3:3–32.
SheaBJ, GrimshawJM, WellsGA, et al.Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007; 7:10.
16.
FlodgrenG, EcclesMP, ShepperdS, et al.An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev, 2011:Cd009255.
17.
AmicoKR. Evidence for technology interventions to promote ART adherence in adult populations: A review of the literature 2012–2015. Curr HIV/AIDS Rep, 2015; 12:441–450.
18.
ClabornKR, FernandezA, WrayT, et al.Computer-based HIV adherence promotion interventions: A systematic review. Transl Behav Med, 2015; 5:294–306.
19.
PellowskiJA, KalichmanSC. Recent advances (2011–2012) in technology-delivered interventions for people living with HIV. Curr HIV/AIDS Rep, 2012; 9:326–334.
20.
WiseJ, OperarioD. Use of electronic reminder devices to improve adherence to antiretroviral therapy: A systematic review. AIDS Patient Care STDs, 2008; 22:495–504.
21.
FinitsisDJ, PellowskiJA, JohnsonBT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): A meta-analysis of randomized controlled trials. PLoS One, 2014; 9:e88166.
22.
GentryS, van-VelthovenMH, Tudor CarL, et al.Telephone Delivered Interventions for Reducing Morbidity and Mortality in People with HIV Infection. Oxford, England: John Wiley, 2013.
23.
HorvathT, AzmanH, KennedyGE, et al.Mobile Phone Text Messaging for Promoting Adherence to Antiretroviral Therapy in Patients with HIV Infection. Oxford, UK: Wiley, 2012.
24.
MuessigKE, GrandS, HorvathKJ, et al.Recent mobile health interventions to support medication adherence among HIV-positive MSM. Curr Opin HIV AIDS, 2017; 12:432–441.
25.
LimaIC, GalvaoMT, Alexandre HdeO, et al.Information and communication technologies for adherence to antiretroviral treatment in adults with HIV/AIDS. Int J Med Inform, 2016; 92:54–61.
26.
SimoniJM, PearsonCR, PantaloneDW, et al.Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr, 2006; 43Suppl 1:S23–S35.
27.
HillS, KavookjianJ. Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: A systematic review of the literature. AIDS Care, 2012; 24:583–592.
28.
RobbinsRN, SpectorAY, MellinsCA, et al.Optimizing ART adherence: Update for HIV treatment and prevention. Curr HIV/AIDS Rep, 2014; 11:423–433.
29.
LangebeekN, NieuwkerkP. Electronic medication monitoring-informed counseling to improve adherence to combination anti-retroviral therapy and virologic treatment outcomes: A meta-analysis. Front Public Health, 2015; 3:139.
30.
FordN, NachegaJB, EngelME, et al.Directly observed antiretroviral therapy: A systematic review and meta-analysis of randomised clinical trials. Lancet, 2009; 374:2064–2071.
31.
HartJE, JeonCY, IversLC, et al.Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: A meta-analysis and systematic review. J Acquir Immune Defic Syndr, 2010; 54:167–179.
32.
NachegaJB, AdetokunbohO, UthmanOA, et al.Community-based interventions to improve and sustain antiretroviral therapy adherence, retention in HIV care and clinical outcomes in low- and middle-income countries for achieving the UNAIDS 90-90-90 targets. Curr HIV/AIDS Rep, 2016; 13:241–255.
33.
KenyaS, ChidaN, SymesS, et al.Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature. HIV Med, 2011; 12:525–534.
34.
RuedaS, Park-WyllieLY, BayoumiAM, et al.Patient Support and Education for Promoting Adherence to Highly Active Antiretroviral Therapy for HIV/AIDS. Chichester, UK: The Cochrane Library/John Wiley & Sons, 2006.
35.
RochaBS, SilveiraMP, MoraesCG, et al.Pharmaceutical interventions in antiretroviral therapy: Systematic review and meta-analysis of randomized clinical trials. J Clin Pharm Ther, 2015; 40:251–258.
36.
SaberiP, DongBJ, JohnsonMO, et al.The impact of HIV clinical pharmacists on HIV treatment outcomes: A systematic review. Patient Prefer Adherence, 2012; 6:297–322.
37.
NachegaJB, ParientiJJ, UthmanOA, et al.Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis, 2014; 58:1297–1307.
38.
ClayPG, NagS, GrahamCM, et al.Meta-analysis of studies comparing single and multi-tablet fixed dose combination HIV treatment regimens. Medicine, 2015; 94:e1677.
39.
FogartyL, RoterD, LarsonS, et al.Patient adherence to HIV medication regimens: A review of published and abstract reports [comment]. Patient Educ Counsel, 2002; 46:93–108.
40.
BarnighausenT, ChaiyachatiK, ChimbindiN, et al.Interventions to increase antiretroviral adherence in sub-Saharan Africa: A systematic review of evaluation studies. Lancet Infect Dis, 2011; 11:942–951.
41.
BonnerK, MezochowA, RobertsT, et al.Viral load monitoring as a tool to reinforce adherence: A systematic review. J Acquir Immune Defic Syndr, 2013; 64:74–78.
42.
ChaiyachatiKH, OgbuojiO, PriceM, et al.Interventions to improve adherence to antiretroviral therapy: A rapid systematic review. AIDS, 2014; 28(Suppl. 2):S187–S204.
43.
CharaniaMR, MarshallKJ, LylesCM, et al.Identification of evidence-based interventions for promoting HIV medication adherence: Findings from a systematic review of U.S.-based studies, 1996–2011. AIDS Behav, 2014; 18:646–660.
44.
MathesT, PieperD, AntoineSL, et al.Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients—A systematic review. HIV Med, 2013; 14:583–595.
45.
MathewsT, AntoineSL, PieperD. Adherence-enhancing interventions for active antiretroviral therapy in sub-Saharan Africa: A systematic review and meta-analysis. Sex Health, 2014; 11:230–239.
46.
MbuagbawL, SivaramalingamB, NavarroT, et al.Interventions for enhancing adherence to antiretroviral therapy (ART): A systematic review of high quality studies. AIDS Patient Care STDs, 2015; 29:248–266.
47.
SimoniJM, FrickPA, PantaloneDW, et al.Antiretroviral adherence interventions: A review of current literature and ongoing studies. Topics HIV Med, 2003; 11:185–198.
48.
YangY. State of the science: The efficacy of a multicomponent intervention for ART adherence among people living with HIV. J Assoc Nurses AIDS Care, 2014; 25:297–308.
49.
KantersS, ParkJJ, ChanK, et al.Interventions to improve adherence to antiretroviral therapy: A systematic review and network meta-analysis. Lancet HIV, 2017; 4:e31–e40.
50.
ArrivillagaM, MartucciV, HoyosPA, et al.Adherence among children and young people living with HIV/AIDS: A systematic review of medication and comprehensive interventions. Vulnerable Children Youth Stud, 2013; 8:321–337.
51.
Bain-BrickleyD, ButlerLM, KennedyGE, et al.Interventions to Improve Adherence to Antiretroviral Therapy in Children with HIV Infection. London, England: John Wiley & Sons, 2011.
52.
ReisnerSL, MimiagaMJ, SkeerM, et al.A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Topics HIV Med, 2009; 17:14–25.
53.
SimoniJM, MontgomeryA, MartinE, et al.Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management. Pediatrics, 2007; 119:e1371–e1383.
54.
ShawS, AmicoKR. Antiretroviral therapy adherence enhancing interventions for adolescents and young adults 13–24 years of age: A review of the evidence base. J Acquir Immune Defic Syndr, 2016; 72:387–399.
55.
BinfordMC, KahanaSY, AlticeFL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep, 2012; 9:287–312.
56.
SimoniJM, PearsonCR, PantaloneDW, et al.Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr, 2006; 43(Suppl. 1):S23–S35.
57.
McCance-KatzEF, GourevitchMN, ArnstenJ, et al.Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J Addict, 2002; 11:271–278.
58.
Smith-RohrbergD, MezgerJ, WaltonM, et al.Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. J Acquir Immune Defic Syndr, 2006; 43Suppl 1:S48–S53.
59.
PradierC, BentzL, SpireB, et al.Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials, 2003; 4:121–131.
60.
Rotheram-BorusMJ, SwendemanD, ComuladaWS, et al.Prevention for substance-using HIV-positive young people: Telephone and in-person delivery. J Acquir Immune Defic Syndr, 2004; 37Suppl 2:S68–S77.
61.
PalmerNB, BasinskiJR, UldallKK. Psychiatric illness, access and adherence to HAART: A brief review of recent findings and implications for care. HIV Ther, 2010; 4:215–230.
62.
BabudieriS, AcetiA, D'OffiziGP, et al.Directly observed therapy to treat HIV infection in prisoners. JAMA, 2000; 284:179–180.
63.
KirklandLR, FischlMA, TashimaKT, et al.Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment. Clin Infect Dis, 2002; 34:511–518.
64.
LanzafameM, TrevenzoliM, CattelanAM, et al.Directly observed therapy in HIV therapy: A realistic perspective?. J Acquir Immune Defic Syndr, 2000; 25:200–201.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
